171 related articles for article (PubMed ID: 27941019)
21. Mechanisms of sustained ventricular tachycardia in myotonic dystrophy: implications for catheter ablation.
Merino JL; Carmona JR; Fernández-Lozano I; Peinado R; Basterra N; Sobrino JA
Circulation; 1998 Aug; 98(6):541-6. PubMed ID: 9714111
[TBL] [Abstract][Full Text] [Related]
22. [The electrotherapy of the arrhythmias in 3 cases of myotonic dystrophy (Steinert's disease)].
Gardini A; Zagami N; Marchini A; Morandi F; Bianchetti F; Curnis A; Politi A
Cardiologia; 1996 Dec; 41(12):1209-14. PubMed ID: 9064216
[TBL] [Abstract][Full Text] [Related]
23. Cardiologic predictors of sudden death in patients with myotonic dystrophy type 1.
Rakocevic Stojanovic V; Peric S; Paunic T; Pavlovic S; Cvitan E; Basta I; Peric M; Milicev M; Lavrnic D
J Clin Neurosci; 2013 Jul; 20(7):1002-6. PubMed ID: 23683744
[TBL] [Abstract][Full Text] [Related]
24. Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy.
Breton R; Mathieu J
Can J Cardiol; 2009 Feb; 25(2):e23-7. PubMed ID: 19214296
[TBL] [Abstract][Full Text] [Related]
25. Bachmann bundle pacing reduces atrial electromechanical delay in type 1 myotonic dystrophy patients.
Russo V; Rago A; Papa AA; Arena G; Politano L; Nigro G
J Interv Card Electrophysiol; 2018 Apr; 51(3):229-236. PubMed ID: 29488106
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular manifestations of myotonic dystrophy.
Wahbi K; Furling D
Trends Cardiovasc Med; 2020 May; 30(4):232-238. PubMed ID: 31213350
[TBL] [Abstract][Full Text] [Related]
27. High prevalence of cardiac involvement in patients with myotonic dystrophy type 1: a cross-sectional study.
Petri H; Witting N; Ersbøll MK; Sajadieh A; Dunø M; Helweg-Larsen S; Vissing J; Køber L; Bundgaard H
Int J Cardiol; 2014 Jun; 174(1):31-6. PubMed ID: 24704412
[TBL] [Abstract][Full Text] [Related]
28. Outcome of Cardiac Sarcoidosis Presenting With High-Grade Atrioventricular Block.
Nordenswan HK; Lehtonen J; Ekström K; Kandolin R; Simonen P; Mäyränpää M; Vihinen T; Miettinen H; Kaikkonen K; Haataja P; Kerola T; Rissanen TT; Kokkonen J; Alatalo A; Pietilä-Effati P; Utriainen S; Kupari M
Circ Arrhythm Electrophysiol; 2018 Aug; 11(8):e006145. PubMed ID: 30354309
[TBL] [Abstract][Full Text] [Related]
29. Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study.
Lazarus A; Varin J; Babuty D; Anselme F; Coste J; Duboc D
J Am Coll Cardiol; 2002 Nov; 40(9):1645-52. PubMed ID: 12427418
[TBL] [Abstract][Full Text] [Related]
30. Ventricular tachycardia: first manifestation of myotonic dystrophy.
Cakmak N; Osmonov D; Ozcan KS; Donmez C
Acta Cardiol; 2011 Apr; 66(2):267-9. PubMed ID: 21591591
[TBL] [Abstract][Full Text] [Related]
31. Insufficiency of electrocardiogram alone in predicting infrahisian abnormalities in patients with type 1 myotonic dystrophy.
Siméon E; Patier-Dussauge A; Bernard-Brunet A; Clémenty N; Gouraud JB; Guyomarch B; Magot A; Probst V; Babuty D
Int J Cardiol; 2014 Apr; 172(3):625-7. PubMed ID: 24560399
[No Abstract] [Full Text] [Related]
32. Cardiac manifestations in myotonic dystrophy type 1 patients followed using a standard protocol in a specialized unit.
Facenda-Lorenzo M; Hernández-Afonso J; Rodríguez-Esteban M; de León-Hernández JC; Grillo-Pérez JJ
Rev Esp Cardiol (Engl Ed); 2013 Mar; 66(3):193-7. PubMed ID: 24775453
[TBL] [Abstract][Full Text] [Related]
33. Use of the prophylactic implantable cardioverter defibrillator for patients with normal hearts.
Brugada P; Brugada R; Brugada J; Geelen P
Am J Cardiol; 1999 Mar; 83(5B):98D-100D. PubMed ID: 10089849
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular manifestations of myotonic dystrophy-1.
Sovari AA; Bodine CK; Farokhi F
Cardiol Rev; 2007; 15(4):191-4. PubMed ID: 17575483
[TBL] [Abstract][Full Text] [Related]
36. Cardiac resynchronization improves heart failure in one patient with myotonic dystrophy type 1. A case report.
Russo V; Rago A; Antonio Papa A; Nigro G
Acta Myol; 2012 Oct; 31(2):154-5. PubMed ID: 23097608
[TBL] [Abstract][Full Text] [Related]
37. Sex Differences in the Risk of First and Recurrent Ventricular Tachyarrhythmias Among Patients Receiving an Implantable Cardioverter-Defibrillator for Primary Prevention.
Saxena S; Goldenberg I; McNitt S; Hsich E; Kutyifa V; Bragazzi NL; Polonsky B; Aktas MK; Huang DT; Rosero S; Klein H; Zareba W; Younis A
JAMA Netw Open; 2022 Jun; 5(6):e2217153. PubMed ID: 35699956
[TBL] [Abstract][Full Text] [Related]
38. A 34-year longitudinal study on long-term cardiac outcomes in DM1 patients with normal ECG at baseline at an Italian clinical centre.
Bucci E; Testa M; Licchelli L; Frattari A; El Halabieh NA; Gabriele E; Pignatelli G; De Santis T; Fionda L; Vanoli F; Morino S; Garibaldi M; Di Pasquale A; Vanacore N; Botta A; Antonini G
J Neurol; 2018 Apr; 265(4):885-895. PubMed ID: 29429070
[TBL] [Abstract][Full Text] [Related]
39. Clinical predictors of conduction disease progression in type I myotonic muscular dystrophy.
Nazarian S; Wagner KR; Caffo BS; Tomaselli GF
Pacing Clin Electrophysiol; 2011 Feb; 34(2):171-6. PubMed ID: 20946286
[TBL] [Abstract][Full Text] [Related]
40. Sustained ventricular tachycardias associated with myotonic dystrophy.
Tamura K; Tsuji H; Matsui Y; Masui A; Hikosaka M; Karakawa M; Iwasaka T; Inada M
Clin Cardiol; 1996 Aug; 19(8):674-7. PubMed ID: 8864345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
